Calcitonin gene-related peptide (CGRP) plays a pivotal role in the pathophysiology of migraine and is an important therapeutic target. Monoclonal antibodies that inhibit CGRP binding to its receptor ...

If you live with migraine disease, you’ve likely been asked the question, “What causes migraine?” Like many of us, you may struggle to come up with a succinct response that clearly explains the ...

Tension headaches and migraines are the most common types of head pains, yet the exact source of those conditions has alluded experts — until now. A research team in Germany studied magnetic resonance ...

Novel formulation of intranasal oxytocin contains magnesium (Mg2+), shown to potentiate the analgesic effects of oxytocin on the oxytocin receptor in animal models TNX-1900 blocks release of CGRP, a ...

A recent Scientific Reports study investigated the association between migraine and the development of inflammatory bowel disease (IBD). Study: Migraine is associated with the development of adult ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers of ...